161 related articles for article (PubMed ID: 23295253)
1. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.
Brill AK; Ott SR; Geiser T
Respiration; 2013; 86(5):376-83. PubMed ID: 23295253
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of mycophenolate mofetil in sarcoidosis.
Hamzeh N; Voelker A; Forssén A; Gottschall EB; Rose C; Mroz P; Maier LA
Respir Med; 2014 Nov; 108(11):1663-9. PubMed ID: 25301291
[TBL] [Abstract][Full Text] [Related]
3. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.
Androdias G; Maillet D; Marignier R; Pinède L; Confavreux C; Broussolle C; Vukusic S; Sève P
Neurology; 2011 Mar; 76(13):1168-72. PubMed ID: 21444902
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil as an alternative treatment in sarcoidosis.
Papiris S; Stagaki E; Papadaki G; Kolilekas L; Korbila I; Apollonatou V; Kallieri M; Gialafos H; Chatziioannou S; Papaioannou AI; Manali ED
Pulm Pharmacol Ther; 2019 Oct; 58():101840. PubMed ID: 31518648
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients.
Siepmann K; Huber M; Stübiger N; Deuter C; Zierhut M
Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
7. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
Miehsler W; Reinisch W; Moser G; Gangl A; Vogelsang H
Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil in the treatment of uveitis in children.
Doycheva D; Deuter C; Stuebiger N; Biester S; Zierhut M
Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275
[TBL] [Abstract][Full Text] [Related]
11. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
12. Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis.
Yap DY; Ma MK; Mok MM; Tang CS; Chan TM
Rheumatology (Oxford); 2013 Mar; 52(3):480-6. PubMed ID: 23148090
[TBL] [Abstract][Full Text] [Related]
13. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
14. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis].
Greiner K; Varikkara M; Santiago C; Forrester JV
Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257
[TBL] [Abstract][Full Text] [Related]
15. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Abu El-Asrar AM; Hemachandran S; Al-Mezaine HS; Kangave D; Al-Muammar AM
Acta Ophthalmol; 2012 Dec; 90(8):e603-8. PubMed ID: 22971163
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
Fujinaga S; Ohtomo Y; Hirano D; Nishizaki N; Someya T; Ohtsuka Y; Kaneko K; Shimizu T
Clin Nephrol; 2009 Oct; 72(4):268-73. PubMed ID: 19825332
[TBL] [Abstract][Full Text] [Related]
17. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
Budde K; Glander P; Diekmann F; Dragun D; Waiser J; Fritsche L; Neumayer HH
Transplant Proc; 2004 Mar; 36(2 Suppl):524S-527S. PubMed ID: 15041401
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil in the treatment of SLE and systemic vasculitis: experience at a single university center.
Lourdudoss C; Vollenhoven Rv
Lupus; 2014 Mar; 23(3):299-304. PubMed ID: 24399811
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
Koukoulaki M; Jayne DR
Nephron Clin Pract; 2006; 102(3-4):c100-7. PubMed ID: 16286784
[TBL] [Abstract][Full Text] [Related]
20. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].
Ballester I; Silvestre JF; Pérez-Crespo M; Lucas A
Actas Dermosifiliogr; 2009 Dec; 100(10):883-7. PubMed ID: 20038365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
